Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 39 | 2019 | 441 | 8.180 |
Why?
|
Silymarin | 34 | 2016 | 38 | 6.330 |
Why?
|
Exosomes | 6 | 2019 | 38 | 3.090 |
Why?
|
Signal Transduction | 18 | 2019 | 666 | 2.370 |
Why?
|
Cell Line, Tumor | 37 | 2019 | 681 | 2.310 |
Why?
|
Antineoplastic Agents | 13 | 2018 | 546 | 1.910 |
Why?
|
Antineoplastic Agents, Phytogenic | 9 | 2019 | 38 | 1.820 |
Why?
|
Cell Proliferation | 21 | 2019 | 573 | 1.810 |
Why?
|
Apoptosis | 19 | 2015 | 337 | 1.750 |
Why?
|
Antioxidants | 17 | 2016 | 114 | 1.740 |
Why?
|
Neoplasms | 5 | 2018 | 611 | 1.360 |
Why?
|
Plant Extracts | 6 | 2016 | 60 | 1.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 11 | 2019 | 249 | 1.160 |
Why?
|
Animals | 46 | 2019 | 7299 | 1.130 |
Why?
|
Male | 53 | 2019 | 17815 | 1.100 |
Why?
|
Cell Hypoxia | 5 | 2016 | 39 | 1.080 |
Why?
|
Cell Movement | 7 | 2019 | 161 | 1.070 |
Why?
|
Cell Cycle Proteins | 7 | 2015 | 48 | 1.070 |
Why?
|
Cell Survival | 12 | 2018 | 272 | 1.040 |
Why?
|
Mice | 32 | 2019 | 2370 | 1.030 |
Why?
|
Humans | 65 | 2019 | 29123 | 1.010 |
Why?
|
Oxidative Stress | 5 | 2017 | 223 | 1.000 |
Why?
|
African Americans | 4 | 2019 | 1373 | 0.960 |
Why?
|
Cadherins | 4 | 2016 | 24 | 0.950 |
Why?
|
Pentacyclic Triterpenes | 2 | 2014 | 2 | 0.920 |
Why?
|
Anticarcinogenic Agents | 8 | 2014 | 24 | 0.900 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2018 | 69 | 0.900 |
Why?
|
Neovascularization, Pathologic | 5 | 2016 | 81 | 0.890 |
Why?
|
Skin Neoplasms | 7 | 2019 | 206 | 0.890 |
Why?
|
Neoplasm Invasiveness | 5 | 2018 | 189 | 0.890 |
Why?
|
Milk Thistle | 7 | 2016 | 7 | 0.870 |
Why?
|
Cell Cycle | 6 | 2015 | 69 | 0.850 |
Why?
|
Prostate | 6 | 2018 | 68 | 0.800 |
Why?
|
Proteome | 2 | 2019 | 34 | 0.790 |
Why?
|
Mice, Nude | 15 | 2015 | 276 | 0.770 |
Why?
|
Xenograft Model Antitumor Assays | 11 | 2016 | 113 | 0.730 |
Why?
|
Carcinoma | 4 | 2011 | 87 | 0.730 |
Why?
|
Qa-SNARE Proteins | 1 | 2019 | 4 | 0.690 |
Why?
|
NF-kappa B | 6 | 2016 | 75 | 0.690 |
Why?
|
Receptors, Androgen | 2 | 2010 | 39 | 0.680 |
Why?
|
Proteomics | 1 | 2019 | 92 | 0.640 |
Why?
|
Integrins | 2 | 2015 | 20 | 0.640 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2018 | 23 | 0.630 |
Why?
|
Disease Progression | 5 | 2017 | 572 | 0.620 |
Why?
|
Carcinoma, Renal Cell | 1 | 2019 | 109 | 0.620 |
Why?
|
Placenta | 1 | 2018 | 63 | 0.610 |
Why?
|
Lipid Metabolism | 3 | 2016 | 100 | 0.610 |
Why?
|
Organoids | 1 | 2018 | 68 | 0.600 |
Why?
|
Adenocarcinoma | 4 | 2016 | 301 | 0.600 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2016 | 22 | 0.600 |
Why?
|
Phenotype | 1 | 2019 | 629 | 0.590 |
Why?
|
Ultraviolet Rays | 5 | 2019 | 46 | 0.590 |
Why?
|
Carcinoma, Basal Cell | 4 | 2019 | 27 | 0.580 |
Why?
|
Neoplasm Proteins | 4 | 2014 | 141 | 0.580 |
Why?
|
Lipogenesis | 1 | 2016 | 18 | 0.570 |
Why?
|
Metabolomics | 1 | 2016 | 45 | 0.570 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 2016 | 10 | 0.570 |
Why?
|
Biomedical Research | 1 | 2018 | 153 | 0.560 |
Why?
|
Transcription Factors | 2 | 2014 | 172 | 0.560 |
Why?
|
DNA Damage | 6 | 2019 | 88 | 0.560 |
Why?
|
Momordica charantia | 3 | 2018 | 3 | 0.540 |
Why?
|
Stem Cells | 1 | 2018 | 292 | 0.530 |
Why?
|
Cyclin-Dependent Kinases | 4 | 2008 | 10 | 0.520 |
Why?
|
Flavonolignans | 2 | 2012 | 2 | 0.520 |
Why?
|
Fibronectins | 1 | 2014 | 34 | 0.510 |
Why?
|
Oxygen | 1 | 2015 | 139 | 0.500 |
Why?
|
Triglycerides | 1 | 2015 | 214 | 0.500 |
Why?
|
Neoplasm Metastasis | 3 | 2014 | 199 | 0.500 |
Why?
|
Stomach Neoplasms | 2 | 2005 | 85 | 0.490 |
Why?
|
Adherens Junctions | 1 | 2013 | 1 | 0.490 |
Why?
|
Angiogenesis Inhibitors | 2 | 2011 | 34 | 0.490 |
Why?
|
Endothelial Cells | 2 | 2015 | 179 | 0.490 |
Why?
|
Drug Delivery Systems | 1 | 2014 | 92 | 0.470 |
Why?
|
Carcinogens | 4 | 2013 | 34 | 0.460 |
Why?
|
Glioblastoma | 1 | 2014 | 143 | 0.450 |
Why?
|
Biological Products | 2 | 2015 | 66 | 0.430 |
Why?
|
Blotting, Western | 7 | 2014 | 281 | 0.430 |
Why?
|
Prognosis | 4 | 2019 | 1362 | 0.390 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2016 | 69 | 0.380 |
Why?
|
Glioma | 1 | 2011 | 133 | 0.370 |
Why?
|
Pancreatic Neoplasms | 3 | 2018 | 131 | 0.360 |
Why?
|
Kava | 1 | 2008 | 1 | 0.340 |
Why?
|
Brain Neoplasms | 1 | 2014 | 587 | 0.330 |
Why?
|
Protective Agents | 1 | 2008 | 4 | 0.330 |
Why?
|
Mitogen-Activated Protein Kinases | 3 | 2018 | 37 | 0.330 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2014 | 142 | 0.330 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2008 | 8 | 0.320 |
Why?
|
Cytoplasm | 3 | 2019 | 30 | 0.320 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2008 | 401 | 0.320 |
Why?
|
Benzo(a)pyrene | 2 | 2005 | 4 | 0.320 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2018 | 90 | 0.310 |
Why?
|
Mice, Transgenic | 6 | 2019 | 249 | 0.310 |
Why?
|
Pyrones | 2 | 2018 | 3 | 0.300 |
Why?
|
AMP-Activated Protein Kinases | 3 | 2017 | 19 | 0.300 |
Why?
|
Head and Neck Neoplasms | 3 | 2014 | 117 | 0.300 |
Why?
|
Immunohistochemistry | 4 | 2019 | 519 | 0.300 |
Why?
|
Anthocyanins | 2 | 2017 | 3 | 0.290 |
Why?
|
Autophagy | 2 | 2018 | 53 | 0.290 |
Why?
|
Flavones | 1 | 2006 | 1 | 0.280 |
Why?
|
Fibroblasts | 3 | 2016 | 103 | 0.280 |
Why?
|
Terminalia | 1 | 2005 | 1 | 0.280 |
Why?
|
Phyllanthus emblica | 1 | 2005 | 1 | 0.280 |
Why?
|
Plant Preparations | 1 | 2005 | 21 | 0.270 |
Why?
|
Phytotherapy | 1 | 2005 | 38 | 0.270 |
Why?
|
DNA Repair | 4 | 2015 | 50 | 0.270 |
Why?
|
European Continental Ancestry Group | 3 | 2019 | 1131 | 0.270 |
Why?
|
Disease Models, Animal | 7 | 2019 | 980 | 0.260 |
Why?
|
Neurons | 2 | 2019 | 394 | 0.250 |
Why?
|
Vascular Endothelial Growth Factor A | 6 | 2011 | 103 | 0.250 |
Why?
|
Microscopy, Confocal | 3 | 2015 | 62 | 0.250 |
Why?
|
Grape Seed Extract | 2 | 2014 | 2 | 0.250 |
Why?
|
Macrophages | 2 | 2019 | 188 | 0.250 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2017 | 37 | 0.240 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2017 | 44 | 0.240 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2018 | 50 | 0.240 |
Why?
|
Chemoprevention | 4 | 2019 | 9 | 0.230 |
Why?
|
MAP Kinase Signaling System | 2 | 2015 | 57 | 0.230 |
Why?
|
Cell Nucleus | 3 | 2010 | 105 | 0.230 |
Why?
|
Nitric Oxide Synthase Type II | 4 | 2011 | 12 | 0.230 |
Why?
|
Phosphorylation | 5 | 2014 | 225 | 0.220 |
Why?
|
Lung Neoplasms | 4 | 2011 | 384 | 0.210 |
Why?
|
Transcription Factor AP-1 | 4 | 2016 | 18 | 0.200 |
Why?
|
Cell Separation | 2 | 2018 | 86 | 0.190 |
Why?
|
Enzyme Activation | 5 | 2017 | 126 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2014 | 641 | 0.190 |
Why?
|
Hedgehog Proteins | 2 | 2017 | 11 | 0.180 |
Why?
|
Skin | 4 | 2019 | 203 | 0.180 |
Why?
|
Obesity | 2 | 2018 | 1063 | 0.180 |
Why?
|
Mast Cells | 1 | 2019 | 17 | 0.170 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2019 | 21 | 0.170 |
Why?
|
Neoplasm Staging | 2 | 2019 | 436 | 0.170 |
Why?
|
United States | 2 | 2018 | 3632 | 0.170 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 42 | 0.170 |
Why?
|
Mice, Inbred C57BL | 7 | 2018 | 711 | 0.170 |
Why?
|
Gene Silencing | 1 | 2019 | 49 | 0.170 |
Why?
|
Receptors, Notch | 1 | 2018 | 16 | 0.170 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2019 | 33 | 0.170 |
Why?
|
Tandem Mass Spectrometry | 1 | 2019 | 57 | 0.170 |
Why?
|
Serotonin | 1 | 2018 | 35 | 0.170 |
Why?
|
Molecular Imaging | 1 | 2019 | 22 | 0.170 |
Why?
|
Ascomycota | 1 | 2018 | 4 | 0.170 |
Why?
|
Neural Cell Adhesion Molecule L1 | 1 | 2018 | 2 | 0.160 |
Why?
|
Disease-Free Survival | 1 | 2019 | 281 | 0.160 |
Why?
|
rab5 GTP-Binding Proteins | 1 | 2018 | 3 | 0.160 |
Why?
|
Benzylidene Compounds | 1 | 2018 | 6 | 0.160 |
Why?
|
Aniline Compounds | 1 | 2018 | 25 | 0.160 |
Why?
|
Inflammation Mediators | 1 | 2019 | 101 | 0.160 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 11 | 0.160 |
Why?
|
Antigens, Neoplasm | 1 | 2018 | 44 | 0.160 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 2 | 2008 | 3 | 0.160 |
Why?
|
Dual Specificity Phosphatase 6 | 1 | 2017 | 5 | 0.160 |
Why?
|
Biopsy | 1 | 2019 | 241 | 0.160 |
Why?
|
Cell Line | 3 | 2015 | 450 | 0.150 |
Why?
|
Neoplastic Stem Cells | 1 | 2018 | 90 | 0.150 |
Why?
|
Mitochondria | 2 | 2017 | 174 | 0.150 |
Why?
|
Female | 8 | 2019 | 18173 | 0.150 |
Why?
|
Calcium | 1 | 2019 | 297 | 0.150 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 165 | 0.150 |
Why?
|
Transfection | 2 | 2014 | 192 | 0.150 |
Why?
|
Tumor Cells, Cultured | 4 | 2014 | 158 | 0.150 |
Why?
|
Lipids | 1 | 2018 | 209 | 0.150 |
Why?
|
Healthcare Disparities | 1 | 2019 | 153 | 0.150 |
Why?
|
Stilbenes | 2 | 2013 | 25 | 0.140 |
Why?
|
Talaromyces | 1 | 2016 | 1 | 0.140 |
Why?
|
Terpenes | 1 | 2016 | 4 | 0.140 |
Why?
|
Annonaceae | 1 | 2016 | 1 | 0.140 |
Why?
|
RNA, Small Interfering | 2 | 2014 | 109 | 0.140 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2016 | 57 | 0.140 |
Why?
|
Metabolic Diseases | 1 | 2016 | 17 | 0.140 |
Why?
|
Chemokine CCL2 | 1 | 2016 | 47 | 0.140 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2015 | 15 | 0.140 |
Why?
|
Naphthols | 1 | 2015 | 1 | 0.140 |
Why?
|
Clinical Trials as Topic | 2 | 2008 | 298 | 0.140 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 532 | 0.140 |
Why?
|
Culture Media, Conditioned | 2 | 2016 | 52 | 0.140 |
Why?
|
Cells, Cultured | 3 | 2014 | 799 | 0.140 |
Why?
|
Radiation Tolerance | 1 | 2015 | 22 | 0.140 |
Why?
|
Nuclear Proteins | 2 | 2015 | 71 | 0.140 |
Why?
|
Membrane Glycoproteins | 1 | 2016 | 97 | 0.140 |
Why?
|
Reactive Oxygen Species | 2 | 2017 | 159 | 0.130 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 787 | 0.130 |
Why?
|
Naphthalenes | 1 | 2015 | 40 | 0.130 |
Why?
|
Models, Biological | 2 | 2008 | 373 | 0.130 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2015 | 56 | 0.130 |
Why?
|
Electron Transport Complex III | 1 | 2014 | 1 | 0.130 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2015 | 3 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 22 | 0.130 |
Why?
|
Pregnancy | 1 | 2018 | 815 | 0.130 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2014 | 6 | 0.130 |
Why?
|
Time Factors | 3 | 2008 | 2001 | 0.130 |
Why?
|
Treatment Outcome | 2 | 2016 | 3101 | 0.130 |
Why?
|
Stress, Physiological | 1 | 2014 | 44 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 152 | 0.130 |
Why?
|
Inflammation | 2 | 2016 | 507 | 0.130 |
Why?
|
Tumor Burden | 1 | 2014 | 60 | 0.130 |
Why?
|
Dacarbazine | 1 | 2014 | 29 | 0.130 |
Why?
|
STAT1 Transcription Factor | 2 | 2011 | 12 | 0.130 |
Why?
|
STAT3 Transcription Factor | 2 | 2011 | 22 | 0.120 |
Why?
|
Interleukin-8 | 1 | 2014 | 23 | 0.120 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2014 | 6 | 0.120 |
Why?
|
Glucose | 1 | 2015 | 163 | 0.120 |
Why?
|
Metalloproteases | 1 | 2013 | 3 | 0.120 |
Why?
|
Annexin A2 | 1 | 2013 | 7 | 0.120 |
Why?
|
4-Nitroquinoline-1-oxide | 1 | 2013 | 1 | 0.120 |
Why?
|
Tongue Neoplasms | 1 | 2013 | 5 | 0.120 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 73 | 0.120 |
Why?
|
Thyroid Neoplasms | 1 | 2014 | 28 | 0.120 |
Why?
|
Heat-Shock Proteins | 1 | 2013 | 28 | 0.120 |
Why?
|
Coculture Techniques | 1 | 2013 | 74 | 0.120 |
Why?
|
Momordica | 1 | 2013 | 1 | 0.120 |
Why?
|
Protein Kinases | 1 | 2013 | 28 | 0.110 |
Why?
|
Interleukin-12 | 1 | 2013 | 26 | 0.110 |
Why?
|
RANK Ligand | 1 | 2012 | 4 | 0.110 |
Why?
|
NFATC Transcription Factors | 1 | 2012 | 5 | 0.110 |
Why?
|
Extracellular Matrix | 1 | 2014 | 226 | 0.110 |
Why?
|
Osteoclasts | 1 | 2012 | 22 | 0.110 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 368 | 0.110 |
Why?
|
Seeds | 1 | 2012 | 9 | 0.110 |
Why?
|
Metformin | 1 | 2012 | 19 | 0.110 |
Why?
|
Vitis | 1 | 2012 | 12 | 0.110 |
Why?
|
Protein Biosynthesis | 1 | 2012 | 46 | 0.100 |
Why?
|
Proliferating Cell Nuclear Antigen | 2 | 2008 | 13 | 0.100 |
Why?
|
Enzyme Inhibitors | 2 | 2013 | 162 | 0.100 |
Why?
|
Transplantation, Heterologous | 2 | 2008 | 121 | 0.100 |
Why?
|
Microcirculation | 2 | 2008 | 61 | 0.100 |
Why?
|
src-Family Kinases | 1 | 2011 | 16 | 0.100 |
Why?
|
Cytokines | 2 | 2012 | 243 | 0.100 |
Why?
|
Cell Death | 3 | 2017 | 71 | 0.100 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2010 | 6 | 0.100 |
Why?
|
Brain | 1 | 2018 | 930 | 0.100 |
Why?
|
Caspase 8 | 1 | 2010 | 9 | 0.100 |
Why?
|
Transcription Factor RelA | 1 | 2010 | 22 | 0.100 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2007 | 3 | 0.100 |
Why?
|
Microtubule-Associated Proteins | 2 | 2007 | 33 | 0.090 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 481 | 0.090 |
Why?
|
Colonic Neoplasms | 1 | 2010 | 63 | 0.090 |
Why?
|
Wound Healing | 1 | 2011 | 182 | 0.090 |
Why?
|
Cyclin D1 | 3 | 2019 | 15 | 0.090 |
Why?
|
Aged | 2 | 2019 | 9492 | 0.090 |
Why?
|
Beverages | 1 | 2008 | 19 | 0.080 |
Why?
|
cdc25 Phosphatases | 1 | 2008 | 1 | 0.080 |
Why?
|
Isomerism | 1 | 2008 | 6 | 0.080 |
Why?
|
Cyclins | 1 | 2008 | 5 | 0.080 |
Why?
|
Antimitotic Agents | 1 | 2008 | 2 | 0.080 |
Why?
|
Gallic Acid | 1 | 2008 | 2 | 0.080 |
Why?
|
Cardiovascular Diseases | 1 | 2016 | 1017 | 0.080 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2008 | 18 | 0.080 |
Why?
|
Middle Aged | 2 | 2019 | 10834 | 0.080 |
Why?
|
Prostate-Specific Antigen | 1 | 2008 | 61 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2008 | 83 | 0.080 |
Why?
|
Flow Cytometry | 1 | 2008 | 172 | 0.080 |
Why?
|
Down-Regulation | 1 | 2008 | 143 | 0.080 |
Why?
|
Mitosis | 1 | 2007 | 22 | 0.080 |
Why?
|
Light | 1 | 2007 | 25 | 0.080 |
Why?
|
Stereoisomerism | 1 | 2007 | 21 | 0.080 |
Why?
|
Caspases | 1 | 2007 | 31 | 0.080 |
Why?
|
Colorectal Neoplasms | 1 | 2009 | 208 | 0.070 |
Why?
|
Shock, Hemorrhagic | 1 | 1986 | 23 | 0.070 |
Why?
|
Immunoblotting | 2 | 2017 | 50 | 0.070 |
Why?
|
Calcium Channel Blockers | 1 | 1986 | 49 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2007 | 90 | 0.070 |
Why?
|
Body Weight | 2 | 2008 | 290 | 0.070 |
Why?
|
Neoplasm Transplantation | 3 | 2014 | 76 | 0.070 |
Why?
|
Lipid Peroxidation | 1 | 2005 | 34 | 0.070 |
Why?
|
Hemodynamics | 1 | 1986 | 148 | 0.070 |
Why?
|
Gene Expression | 2 | 2018 | 332 | 0.070 |
Why?
|
Molecular Structure | 2 | 2016 | 53 | 0.060 |
Why?
|
Mice, Hairless | 2 | 2016 | 2 | 0.060 |
Why?
|
Mice, Knockout | 2 | 2016 | 425 | 0.060 |
Why?
|
Oxidation-Reduction | 2 | 2015 | 250 | 0.060 |
Why?
|
Neoplasms, Experimental | 1 | 2004 | 27 | 0.060 |
Why?
|
Cell Division | 2 | 2015 | 97 | 0.060 |
Why?
|
Caspase 3 | 2 | 2013 | 30 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2014 | 436 | 0.050 |
Why?
|
Immunoenzyme Techniques | 2 | 2012 | 46 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2012 | 10 | 0.050 |
Why?
|
Receptor, Serotonin, 5-HT1B | 1 | 2018 | 1 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2018 | 23 | 0.040 |
Why?
|
Fresh Water | 1 | 2018 | 4 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 72 | 0.040 |
Why?
|
Sepharose | 1 | 2018 | 5 | 0.040 |
Why?
|
Biotinylation | 1 | 2018 | 10 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2018 | 155 | 0.040 |
Why?
|
Protein Binding | 1 | 2018 | 199 | 0.040 |
Why?
|
Bacterial Proteins | 1 | 2018 | 77 | 0.040 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 2016 | 2 | 0.040 |
Why?
|
Plant Leaves | 1 | 2016 | 4 | 0.040 |
Why?
|
Molecular Conformation | 1 | 2016 | 8 | 0.040 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2016 | 18 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2016 | 77 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 1 | 2016 | 55 | 0.040 |
Why?
|
Xeroderma Pigmentosum Group A Protein | 1 | 2015 | 1 | 0.030 |
Why?
|
DNA Helicases | 1 | 2015 | 5 | 0.030 |
Why?
|
Dermis | 1 | 2015 | 12 | 0.030 |
Why?
|
Penicillium | 1 | 2015 | 1 | 0.030 |
Why?
|
Diketopiperazines | 1 | 2015 | 1 | 0.030 |
Why?
|
Lactones | 1 | 2015 | 11 | 0.030 |
Why?
|
Radiation, Ionizing | 1 | 2015 | 22 | 0.030 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2015 | 6 | 0.030 |
Why?
|
Epoxy Compounds | 1 | 2015 | 5 | 0.030 |
Why?
|
Antigens, CD | 1 | 2016 | 100 | 0.030 |
Why?
|
Indoles | 1 | 2015 | 58 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 248 | 0.030 |
Why?
|
Cytoprotection | 1 | 2014 | 5 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 142 | 0.030 |
Why?
|
Tumor Stem Cell Assay | 1 | 2014 | 12 | 0.030 |
Why?
|
Metribolone | 1 | 2014 | 1 | 0.030 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2014 | 4 | 0.030 |
Why?
|
Mitochondrial Membranes | 1 | 2014 | 21 | 0.030 |
Why?
|
Body Mass Index | 1 | 2018 | 865 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2016 | 139 | 0.030 |
Why?
|
Age Factors | 1 | 2018 | 1108 | 0.030 |
Why?
|
Deoxycytidine | 1 | 2015 | 63 | 0.030 |
Why?
|
Thiazoles | 1 | 2014 | 32 | 0.030 |
Why?
|
Pyridines | 1 | 2014 | 78 | 0.030 |
Why?
|
I-kappa B Proteins | 1 | 2014 | 10 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 172 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2015 | 138 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 1 | 2013 | 9 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2015 | 176 | 0.030 |
Why?
|
Tongue | 1 | 2013 | 13 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2013 | 11 | 0.030 |
Why?
|
Cytosol | 1 | 2013 | 25 | 0.030 |
Why?
|
Radiation-Protective Agents | 1 | 2013 | 5 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2013 | 82 | 0.030 |
Why?
|
Epidermis | 1 | 2013 | 23 | 0.030 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2012 | 17 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 160 | 0.030 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 2012 | 1 | 0.030 |
Why?
|
beta-Transducin Repeat-Containing Proteins | 1 | 2012 | 1 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2012 | 1 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2012 | 2 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2012 | 2 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 3 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2012 | 4 | 0.030 |
Why?
|
Cyclin E | 1 | 2012 | 5 | 0.030 |
Why?
|
rho GTP-Binding Proteins | 1 | 2012 | 9 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 20 | 0.030 |
Why?
|
G2 Phase | 1 | 2012 | 14 | 0.030 |
Why?
|
Pyrimidine Dimers | 1 | 2011 | 1 | 0.030 |
Why?
|
Janus Kinase 1 | 1 | 2011 | 4 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 82 | 0.030 |
Why?
|
RNA Interference | 1 | 2011 | 76 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 100 | 0.020 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2008 | 4 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 6 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2007 | 20 | 0.020 |
Why?
|
Species Specificity | 1 | 2007 | 84 | 0.020 |
Why?
|
Administration, Oral | 1 | 2008 | 169 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 31 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 36 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2008 | 162 | 0.020 |
Why?
|
Urethane | 1 | 2006 | 1 | 0.020 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2006 | 17 | 0.020 |
Why?
|
Epinephrine | 1 | 1986 | 41 | 0.020 |
Why?
|
Angiotensins | 1 | 1986 | 49 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2006 | 50 | 0.020 |
Why?
|
Clonidine | 1 | 1986 | 60 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2008 | 192 | 0.020 |
Why?
|
Adult | 1 | 2018 | 8426 | 0.020 |
Why?
|
Diet | 1 | 2007 | 355 | 0.020 |
Why?
|
Rats | 1 | 1986 | 1604 | 0.010 |
Why?
|